Egypt vs South Korea: Immunization, Hib3 (% of children ages 12-23 months)
Egypt
97.0%
in 2024
South Korea
97.0%
in 2024
Egypt rank
29th
South Korea rank
29th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Egypt
- South Korea
How they compare
Egypt currently reports 97.0% against 97.0% in South Korea, a difference of 0.0%.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was South Korea ahead.
Egypt ranks 29th and South Korea ranks 29th of 191 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Egypt | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.3% | 97.5% | 3.2% | South Korea |
| 2020s | 96.0% | 96.6% | 0.6% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Egypt or South Korea?
- Egypt, at 97.0% against 97.0% in South Korea as of 2024.
- What is the difference in immunization, hib3 between Egypt and South Korea?
- 0.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and South Korea?
- 11 years are reported by both, from 2014 to 2024.
- How do Egypt and South Korea rank globally for immunization, hib3?
- Egypt ranks 29th and South Korea ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.